AR and hepatocellular carcinoma: Early studies on AR in HCC found that mice without hepatic AR expression had slower carcinogen-mediated HCC progression and smaller tumors compared to mice with AR even in the presence of similar levels of testosterone, indicating that hepatic AR action and not circulating androgens themselves are the key feature in dimorphic HCC progression [6].